Vanthys Pharmaceutical Development Private Limited, a dissolved (liquidated) private limited company, was established on 11 May 2009 in Noida, Uttar Pradesh, India. Engaging in pharma contract r&d within the pharma sector, it holds CIN: U73100UP2009PTC037333. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹22.50 Cr and a paid-up capital of ₹22.50 Cr.
It upholds a compliant status. Its leadership includes Benny Thomas (Director), Saravanakumar Dhakshinamoorthy (Additional Director), Shwetank Tiwari (Company Secretary). Past directors included Prakash Chandra Bisht, Hari Shanker Bhartia, Shyam Nath Singh. Its latest AGM occurred on 20 September 2018, with the balance sheet filed on 31 March 2018. It is based at 1A, Sector 16A Institutional Area, Noida, Uttar Pradesh, 201301.
U73100UP2009PTC037333
037333
11 May 2009
₹22.50 Cr
₹22.50 Cr
Roc Kanpur
Unlisted
Dissolved (Liquidated)
Explore comprehensive insights into Vanthys Pharmaceutical Development Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Benny Thomas | Director | 28 Mar 2018 | Current |
| Saravanakumar Dhakshinamoorthy | Additional Director | 15 May 2019 | Current |
| Shwetank Tiwari | Company Secretary | 16 Jan 2018 | Current |
| Shyamsundar Bang | Director | 28 Mar 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 18 Jan 2018 | Past |
| Pramod Abcsdd | Director | 06 Mar 2013 | Past |
| Pramod Abcsdd | Director | 28 Mar 2018 | Past |
| Pramod Abcsdd | Director | 28 Mar 2018 | Past |
| Pramod Abcsdd | Company Secretary | 03 Apr 2013 | Past |
| Pramod Abcsdd | Key Managerial Personnel | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Vanthys Pharmaceutical Development Private Limited, for the financial year ended 2018, experienced modest growth in revenue, with a 0.03% increase. The company also saw a slight improvement in profitability, with a 8.39% increase in profit. The company's net worth moved up by a moderate rise of 6.02%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Vanthys Pharmaceutical Development had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Vanthys Pharmaceutical Development, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Vanthys Pharmaceutical Development, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vanthys Pharmaceutical Development's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Saravanakumar Dhakshinamoorthy was appointed as a Additional Director was appointed as a Additional Director on 15 May 2019 & has been associated with this company since 6 years 6 months . was completed.
Vanthys Pharmaceutical Development Private Limited last Annual general meeting of members was held on 20 Sep 2018 as per latest MCA records. was recorded as a recent event.
The activity Vanthys Pharmaceutical Development Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Kanpur. was completed.
The activity Benny Thomas was appointed as a Director was appointed as a Director on 28 Mar 2018 & has been associated with this company since 7 years 8 months . was completed.
Shyamsundar Bang was appointed as a Director was appointed as a Director on 28 Mar 2018 & has been associated with this company since 7 years 8 months . was recorded as a recent event.
The activity Shwetank Tiwari was appointed as a Company Secretary was appointed as a Company Secretary on 16 Jan 2018 & has been associated with this company since 7 years 10 months . was completed.
The company, which is a Contract Research Development and Manufacturing Organisation (CRDMO), offers comprehensive drug discovery, development and manufacturing services to global healthcare companies.
The CIN of Vanthys Pharmaceutical Development Private Limited is U73100UP2009PTC037333.
Vanthys Pharmaceutical Development Private Limited is headquartered at 1A, Sector 16A Institutional Area, Noida, Uttar Pradesh, 201301.
Vanthys Pharmaceutical Development Private Limited was incorporated on 11 May 2009.
The current directors of Vanthys Pharmaceutical Development Private Limited are
The primary industry of Vanthys Pharmaceutical Development Private Limited is Pharma.
Vanthys Pharmaceutical Development Private Limited is unlisted.
The authorized capital of Vanthys Pharmaceutical Development Private Limited is ₹22.50 Cr, and the paid-up capital is ₹22.50 Cr.
The compliance status of Vanthys Pharmaceutical Development Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX